Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1186/S12916-025-03910-9 | ||||
| Año | 2025 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
BackgroundAntenatal steroid (ANS) therapy is given to women at risk of preterm delivery to accelerate fetal lung maturation. However, the benefit of ANS therapy is variable and how maternal and fetal factors contribute to this observed variability is unknown. We aimed to test the degree of concordance in preterm lung function, and correlate this with genomic, transcriptomic, and pharmacokinetic variables in preterm dizygotic twin ovine fetuses.MethodsThirty-one date-mated ewes carrying twin fetuses at 123 +/- 1 days' gestation received maternal intramuscular injections of either (i) 1 x 0.25 mg/kg betamethasone phosphate and acetate (CS1, n = 11 twin pairs) or (ii) 2 x 0.25 mg/kg betamethasone phosphate and acetate, 24 h apart (CS2, n = 10 twin pairs) or (iii) 2 x saline, 24 h apart (negative control, n = 10 twin pairs). Fetuses were surgically delivered 24 h after their final treatment and ventilated for 30 min.ResultsANS-exposed female fetuses had lower arterial partial pressure of carbon dioxide (PaCO2) values than male fetuses (76.5 +/- 38.0 vs. 97.2 +/- 42.5 mmHg), although the observed difference was not statistically significant (p = 0.1). Only 52% of ANS-treated twins were concordant for lung maturation responses. There was no difference in fetal lung tissue or plasma steroid concentrations within or between twin pairs. Genomic analysis identified 13 single-nucleotide polymorphisms (SNPs) statistically associated with ANS-responsiveness, including in the proto-oncogene MET and the transcription activator STAT1.ConclusionsTwin fetal responses and ANS tissue levels were comparable with those from singleton fetuses in earlier studies. Twin ovine fetuses thus benefit from ANS in a similar manner to singleton fetuses, and a larger dose of betamethasone is not required. Assuming no difference in input from the placental or maternal compartments, fetal lung responses to ANS therapy in dizygotic twin preterm lambs are dependent on the fetus itself. These data suggest a potential heritable role in determining ANS responsiveness.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Fee, Erin L. | - |
Univ Western Australia - Australia
UWA Medical School - Australia The University of Western Australia - Australia |
| 2 | Usuda, Haruo | - |
Univ Western Australia - Australia
Tohoku Univ Hosp - Japón UWA Medical School - Australia Tohoku University Hospital - Japón The University of Western Australia - Australia |
| 3 | Carter, Sean W. D. | - |
Natl Univ Singapore - Singapur
NUS Yong Loo Lin School of Medicine - Singapur |
| 4 | Ikeda, Hideyuki | - |
Tohoku Univ Hosp - Japón
Tohoku University Hospital - Japón |
| 5 | Takahashi, Tsukasa | - |
Tohoku Univ Hosp - Japón
Tohoku University Hospital - Japón |
| 6 | Takahashi, Yuki | - |
Tohoku Univ Hosp - Japón
Tohoku University Hospital - Japón |
| 7 | Kumagai, Yusaku | - |
Tohoku Univ Hosp - Japón
Natl Univ Singapore - Singapur Tohoku University Hospital - Japón NUS Yong Loo Lin School of Medicine - Singapur |
| 8 | Clarke, Michael W. | - |
Univ Western Australia - Australia
The University of Western Australia - Australia |
| 9 | Ireland, Demelza J. | - |
Univ Western Australia - Australia
UWA Medical School - Australia The University of Western Australia - Australia |
| 10 | Newnham, John P. | - |
Univ Western Australia - Australia
UWA Medical School - Australia The University of Western Australia - Australia |
| 11 | Saito, Masatoshi | - |
Univ Western Australia - Australia
Tohoku Univ Hosp - Japón UWA Medical School - Australia Tohoku University Hospital - Japón The University of Western Australia - Australia |
| 12 | Illanes, Sebastian E. | - |
Natl Univ Singapore - Singapur
Universidad de Los Andes, Chile - Chile Center of Interventional Medicine for Precision and Advanced Cellular Therapy (IMPACT) - Chile NUS Yong Loo Lin School of Medicine - Singapur Centro de Medicina Intervencional de Precisión y Terapia Celular Avanzada - Chile |
| 13 | Sesurajan, Binny Priya | - |
Natl Univ Singapore - Singapur
NUS Yong Loo Lin School of Medicine - Singapur |
| 14 | Shen, Liang | - |
Natl Univ Singapore - Singapur
NUS Yong Loo Lin School of Medicine - Singapur |
| 15 | Choolani, Mahesh A. | - |
Natl Univ Singapore - Singapur
NUS Yong Loo Lin School of Medicine - Singapur |
| 16 | Oguz, Gokce | - |
ASTAR - Singapur
A-Star, Genome Institute of Singapore - Singapur |
| 17 | Ramasamy, Adaikalavan | - |
Natl Univ Singapore - Singapur
ASTAR - Singapur NUS Yong Loo Lin School of Medicine - Singapur A-Star, Genome Institute of Singapore - Singapur |
| 18 | Ritchie, Sara | - | |
| 19 | Ritchie, Andrew | - | |
| 20 | Jobe, Alan H. | - |
UNIV CINCINNATI - Estados Unidos
University of Cincinnati College of Medicine - Estados Unidos |
| 21 | Kemp, Matthew W. | - |
Tohoku Univ Hosp - Japón
Natl Univ Singapore - Singapur Murdoch Univ - Australia Chongqing Med Univ - China Tohoku University Hospital - Japón NUS Yong Loo Lin School of Medicine - Singapur Murdoch University - Australia Chongqing Medical University - China |
| Fuente |
|---|
| Bioplatforms Australia |
| Women and Infants Research Foundation |
| Channel 7 Telethon Trust |
| Stan Perron Charitable Foundation |
| Agradecimiento |
|---|
| This work was supported by the Women and Infants Research Foundation. |
| MWC is affiliated to Metabolomics Australia, University of Western Australia, which receives infrastructure funding from the Western Australian State Government in partnership with the Australian Federal Government, through Bioplatforms Australia and the National Collaborative Research Infrastructure Strategy (NCRIS). |
| Funding was provided by The Channel 7 Telethon Trust, and the Stan Perron Charitable Foundation. |
| MWC is affiliated to Metabolomics Australia, University of Western Australia, which receives infrastructure funding from the Western Australian State Government in partnership with the Australian Federal Government, through Bioplatforms Australia and the National Collaborative Research Infrastructure Strategy (NCRIS). |